1. Home
  2. AUDC vs ENGN Comparison

AUDC vs ENGN Comparison

Compare AUDC & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$8.31

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$7.17

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
ENGN
Founded
1992
1999
Country
Israel
Canada
Employees
N/A
82
Industry
Telecommunications Equipment
Sector
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
647.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AUDC
ENGN
Price
$8.31
$7.17
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$12.50
$21.00
AVG Volume (30 Days)
132.5K
521.9K
Earning Date
05-05-2026
03-09-2026
Dividend Yield
4.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.24
N/A
Revenue Next Year
$2.18
N/A
P/E Ratio
$23.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$2.66
52 Week High
$11.48
$12.25

Technical Indicators

Market Signals
Indicator
AUDC
ENGN
Relative Strength Index (RSI) 58.77 33.99
Support Level $8.13 $6.18
Resistance Level $8.95 $7.33
Average True Range (ATR) 0.24 0.64
MACD 0.09 -0.10
Stochastic Oscillator 75.61 16.62

Price Performance

Historical Comparison
AUDC
ENGN

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: